We are live on
!
Find out more
BC
Blackhill Capital Portfolio holdings
AUM
$1.94B
1-Year Est. Return
18.09%
This Fund
S&P 500
This Quarter
Est. Return
+4.19%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$863M
AUM Growth
+$20.7M
(+2.5%)
Cap. Flow
-$5.52M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
86.12%
Holding
52
New
–
Increased
3
Reduced
11
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.79M |
| 2 |
Merck
MRK
|
+$751K |
| 3 |
Apple
AAPL
|
+$143K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$3.73M |
| 2 |
Baxter International
BAX
|
+$1.63M |
| 3 |
Walt Disney
DIS
|
+$1.01M |
| 4 |
Amazon
AMZN
|
+$796K |
| 5 |
Zimmer Biomet
ZBH
|
+$551K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 52.94% |
| 2 | Healthcare | 32.05% |
| 3 | Technology | 5.99% |
| 4 | Consumer Staples | 2.03% |
| 5 | Communication Services | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Williams-Sonoma
WSM
$29.5B
| $454M | 52.63% |
7,902,740
-1,800
| -0% | -$108K |
|
2
Eli Lilly
LLY
$1.08T
| $53.8M | 6.24% |
147,133
-350
| -0.2% | -$124K |
|
3
AbbVie
ABBV
$442B
| $41.9M | 4.86% |
259,560
| – | – |
|
|
4
Apple
AAPL
$4.45T
| $34.2M | 3.96% |
263,000
+1,000
| +0.4% | +$143K |
|
5
Abbott
ABT
$190B
| $33.1M | 3.83% |
301,230
| – | – |
|
|
6
Bristol-Myers Squibb
BMY
$130B
| $31.7M | 3.68% |
440,864
+23,800
| +6% | +$1.79M |
|
7
Johnson & Johnson
JNJ
$626B
| $27.9M | 3.23% |
157,830
| – | – |
|
|
8
Zoetis
ZTS
$31.1B
| $25M | 2.9% |
170,714
-25,175
| -13% | -$3.73M |
|
|
9
Merck
MRK
$322B
| $24M | 2.79% |
216,600
+7,350
| +4% | +$751K |
|
10
Microsoft
MSFT
$3.74T
| $17.3M | 2% |
72,050
| – | – |
|
11
Pfizer
PFE
$152B
| $16.4M | 1.9% |
320,301
| – | – |
|
12
Caterpillar
CAT
$388B
| $14.4M | 1.67% |
60,000
| – | – |
|
|
13
Walt Disney
DIS
$179B
| $13.6M | 1.57% |
156,300
-10,600
| -6% | -$1.01M |
|
|
14
Zimmer Biomet
ZBH
$18.5B
| $10.6M | 1.23% |
83,150
-4,750
| -5% | -$551K |
|
15
Kimberly-Clark
KMB
$36.1B
| $9.64M | 1.12% |
71,000
| – | – |
|
16
Cigna
CI
$72.4B
| $7.22M | 0.84% |
21,779
| – | – |
|
17
Mastercard
MA
$492B
| $6.95M | 0.81% |
20,000
| – | – |
|
18
Procter & Gamble
PG
$338B
| $6.8M | 0.79% |
44,871
| – | – |
|
19
Berkshire Hathaway Class B
BRK.B
$1.11T
| $6.72M | 0.78% |
21,748
-5
| -0% | -$1.49K |
|
|
20
Berkshire Hathaway Class A
BRK.A
$1.11T
| $2.81M | 0.33% |
6
| – | – |
|
21
Enterprise Products Partners
EPD
$81.8B
| $2.64M | 0.31% |
109,650
| – | – |
|
22
Chevron
CVX
$386B
| $2.07M | 0.24% |
11,550
| – | – |
|
|
MMP
23
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.95M | 0.23% |
38,800
| – | – |
|
24
Medtronic
MDT
$116B
| $1.88M | 0.22% |
24,177
| – | – |
|
|
25
Amazon
AMZN
$2.94T
| $1.69M | 0.2% |
20,100
-8,060
| -29% | -$796K |
|
Similar funds
FFH
OCM
AAA
FC
HC
NIM
CC
DCM
Blackhill Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Blackhill Capital held 52 positions worth $863M, up 2.5% from $842M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 0%. Blackhill Capital opened no new positions and made no exits, leaving the 52-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 53% of assets, down from 56% a quarter earlier, followed by Healthcare and Technology.
- Blackhill Capital added most to Bristol-Myers Squibb in Q4 2022, an estimated $1.79M increase.
- Blackhill Capital's biggest Q4 2022 reduction was Zoetis, cutting an estimated $3.73M.
- Blackhill Capital's ten largest holdings make up 86% of its $863M portfolio in Q4 2022.
- Blackhill Capital opened 0 new positions and closed 0 in Q4 2022.
- Blackhill Capital's portfolio value rose 2.5% quarter-over-quarter to $863M.
Based on Blackhill Capital's 13F filing for Q4 2022, filed 13 Feb 2023.